Ocular delivery of the β-blocker, tilisolol, through the prodrug approach
- 1 May 1993
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 93 (1-3) , 49-60
- https://doi.org/10.1016/0378-5173(93)90163-a
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Hydrolysis of salicylic acid-tyrosine and salicylic acid-methionine prodrugs in the rabbitInternational Journal of Pharmaceutics, 1992
- Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbitsInternational Journal of Pharmaceutics, 1990
- Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropineInternational Journal of Pharmaceutics, 1989
- Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyesInternational Journal of Pharmaceutics, 1989
- Solution viscosity effects on the ocular disposition of cromolyn sodium in the albino rabbitInternational Journal of Pharmaceutics, 1989
- Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system.Journal of Pharmacobio-Dynamics, 1988
- Studies on improved corneal permeability to bunazosin.Journal of Pharmacobio-Dynamics, 1988
- Influence of Corneal Epithelial Integrity on the Penetration of Timolol ProdrugsJournal of Ocular Pharmacology and Therapeutics, 1988
- Influence of some preservatives on the corneal permeability of pilocarpine and dexamethasone, in vitroInternational Journal of Pharmaceutics, 1987
- Ocular therapy with nanoparticulate systems for controlled drug deliveryJournal of Controlled Release, 1985